Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible
PPHMP
PPHMP was delisted on the 5th of January, 2018.
2 hedge funds and large institutions have $69K invested in Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
25% more capital invested
Capital invested by funds: $55K → $69K (+$14K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BWA
Burt Wealth Advisors
North Bethesda,
Maryland
|
+$12.9K |
Top Sellers
PPHMP Hedge Fund Activity: Q1 2015 in Review
2 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible (PPHMP) for Q1 2015, worth a combined $69K — up 25% from $55K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PPHMP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Burt Wealth Advisors, opening a new position worth an estimated $12.9K.
- 2 institutional investors held Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible (PPHMP) as of Q1 2015, up from 1 in Q4 2014.
- Funds reported $69K of Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible stock for Q1 2015, up 25% quarter-over-quarter.
- 1 fund opened new Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible positions in Q1 2015 and 0 closed out, a net change of +1 holder.
- The largest Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible buyer in Q1 2015 was Burt Wealth Advisors, an estimated $12.9K added.
Based on aggregated 13F filings for Q1 2015.